Icahn School of Medicine Myeloid Malignancy Workshop 2024
Icahn School of Medicine Myeloid Malignancy Workshop 2024
Regular price
$20.00 USD
Regular price
$20.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
Icahn School of Medicine Myeloid Malignancy Workshop 2024
Regular price
$20.00
Regular price
$20.00
Sale price
Unit price
per
Icahn School of Medicine Myeloid Malignancy Workshop 2024
Include: 13 videos + 5 pdfs, size: 4.4 GBTarget Audience: internists, clinical and laboratory-based physicians, trainees and laboratory investigators, pharmacists
Information:
Date & Location
Friday, March 8, 2024, 7:00 AM – 6:00 PM, Leon & Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY
Target Audience
Specialties – Academic/Research, Genomic Medicine, Geriatric Medicine, Hematology, Internal Medicine, Multiple Specialties, Nurse Practitioner, Nursing, Oncology, Pathology, Pharmacist, Physician Assistant
Professions – Non-Physician, Nurse, Physician
Course Overview
The Myeloid Malignancy Workshop will be a one day in-person event focused on the science and medicine of myelodysplastic syndromes, myeloproliferative neoplasms, and acute myeloid leukemia. The workshop will include internationally recognized clinical and laboratory experts in the field that will provide focused talks intended to highlight the cutting edge science and recent evidence-based advances in clinical care of myeloid malignancies.
Objectives
- Understand the molecular and immunologic vulnerabilities driving drug development for MDS, MPN and AML
- Select the appropriate evidence based therapies for patients with myeloid malignancies
- Recognize the remaining unmet needs in treating myeloid malignancies
- Discuss strategies to incorporate disease-modifying therapies and strive for deeper responses in patients with myeloproliferative neoplasms
- Discuss the emerging results of clinical trials that are investigating therapies in AML/MDS
- Identify treatment goals for systemic mastocytosis that incorporate next generation kit inhibitors
Icahn School of Medicine Myeloid Malignancy Workshop 2024
Topics:
- BPDCN Current and Future Directions.mp4
BPDCN Current and Future Directions.pdf
DUSP6-RSK1 Pathway in Myeloid Malignancies.mp4
Hematopoietic Stem Cells in Space.mp4
Integrating Targeted Therapies in Acute Myeloid Leukemia.mp4
Integrating Targeted Therapies in Acute Myeloid Leukemia.pdf
MDS Lunch Symposium- Emerging Therapies and Clinical Niches Amy E. DeZern, MD, MHS.mp4
MDS Lunch Symposium- Emerging Therapies and Clinical Niches Lewis R Silverman, MD.mp4
MDS Lunch Symposium- Emerging Therapies and Clinical Niches Rami Komrokji, MD.mp4
MDS Lunch Symposium- Emerging Therapies and Clinical Niches.pdf
Role of the Tumor Microenvironment in Leukemia.mp4
Splicing Leukemia.mp4
State of the Art Management for Systemic Mastocytosis.mp4
State of the Art Management for Systemic Mastocytosis.pdf
Targeting mCALR in MPNs.mp4
Targeting mCALR in MPNs.pdf
Trainee Awards Talks 1.mp4
Trainee Awards Talks 2.mp4
